AAAAAA
Results:
1-12
|
Results: 12
Authors:
Malavaud, B
Dinh, B
Bonnet, E
Izopet, J
Payen, JL
Marchou, B
Citation: B. Malavaud et al., Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection, ANTIVIR TH, 5(1), 2000, pp. 3-5
Authors:
Sailler, L
Marchou, B
Lemozy, J
Bonnet, E
Elias, Z
Cuzin, L
Massip, P
Citation: L. Sailler et al., Successful treatment of Actinobacillus actinomycetemcomitans endocarditis with ofloxacin, CL MICRO IN, 6(1), 2000, pp. 55-56
Authors:
Izopet, J
Massip, P
Souyris, C
Sandres, K
Puissant, B
Obadia, M
Pasquier, C
Bonnet, E
Marchou, B
Puel, J
Citation: J. Izopet et al., Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen, AIDS, 14(15), 2000, pp. 2247-2255
Authors:
Sailler, L
Partensky, J
Marchou, B
Massip, P
Citation: L. Sailler et al., Disseminated tuberculosis with macrophage activation syndrome, REV MED IN, 21, 2000, pp. 322S-325S
Authors:
Saves, M
Raffi, F
Clevenbergh, P
Marchou, B
Waldner-Combernoux, A
Morlat, P
Le Moing, V
Riviere, C
Chene, G
Leport, C
Citation: M. Saves et al., Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients, ANTIM AG CH, 44(12), 2000, pp. 3451-3455
Authors:
Elias, Z
Bonnet, E
Marchou, B
Massip, P
Citation: Z. Elias et al., Neurotoxicity of artemisinin: Possible counseling and treatment of side effects, CLIN INF D, 28(6), 1999, pp. 1330-1331
Authors:
El Guedj, M
Cuzin, L
Gigaud, M
Holley, P
Marchou, B
Citation: M. El Guedj et al., Staphylococcus aureus intramedullary abcess. One case and a review of the literature, MED MAL INF, 29(10), 1999, pp. 647-648
Authors:
Leclerc, C
Marchou, B
Sailler, L
Bonnet, E
Moron, M
Alcayde, S
Servat, M
Duchen, C
Hemery, C
Magnaval, JF
Massip, P
Citation: C. Leclerc et al., A new outbreak of trichinellosis with 117 cases in the Midi-Pyrenees region of France. Epidemiology, clinical features, and management., PATH BIOL, 47(5), 1999, pp. 573-575
Authors:
Izopet, J
Bicart-See, A
Pasquier, C
Sandres, K
Bonnet, E
Marchou, B
Puel, J
Massip, P
Citation: J. Izopet et al., Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine, J MED VIROL, 59(4), 1999, pp. 507-511
Authors:
Izopet, J
Sailler, L
Sandres, K
Pasquier, C
Bonnet, E
Aquilina, C
Puel, J
Massip, P
Marchou, B
Citation: J. Izopet et al., Intermittent selection pressure with zidovudine plus zalcitabine treatmentreduces the emergence in vivo of zidovudine resistance HIV mutations, J MED VIROL, 57(2), 1999, pp. 163-168
Authors:
Izopet, J
Salama, G
Pasquier, C
Sandres, K
Marchou, B
Massip, T
Puel, J
Citation: J. Izopet et al., Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy, J ACQ IMM D, 19(5), 1998, pp. 478-483
Authors:
Le Bras, J
Pradines, B
di Piazza, JP
Durand, R
Godineau, N
Bouchaud, O
Roue, R
Marchou, B
Martet, G
Longuet, C
Parzy, D
Citation: J. Le Bras et al., Plasmodium falciparum resistance to chloroquine and cycloguanil in patients returning to France after a travel in Africa without chemoprophylaxis., B S PATH EX, 91(5BIS), 1998, pp. 490-492
Risultati:
1-12
|